Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Triple Negative Breast Neoplasms × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vascular Malformations 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peutz-Jeghers Syndrome 1 Pancreatic Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Malignant Solid Tumors 1 Lymphoma, Non-Hodgkin 1 Lymphangioma 1 Lymphangioleiomyomatosis 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leiomyoma 1 Kaposiform Hemangioendothelioma 1 Hodgkin Disease 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangioendothelioma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumors 1

Interventions

Carboplatin 13 camrelizumab 11 Capecitabine 11 130-nm albumin-bound paclitaxel 9 Paclitaxel 8 pembrolizumab 7 eribulin 7 Cyclophosphamide 7 Gemcitabine 6 Epirubicin 6 apatinib 5 Cisplatin 5 tislelizumab 4 atezolizumab 4 anlotinib 4 Taxes 4 Nivolumab 4 Bevacizumab 4 Vinorelbine 3 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3 Doxorubicin 3 Docetaxel 3 toripalimab 2 talazoparib 2 fluzoparib 2 famitinib 2 Zoledronic Acid 2 Metformin 2 Injections 2 IPI-549 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03805399 2022-08-10

FUTURE

Fudan University

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡